InsidersTradesSigma
Follow the 君实生物 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 君实生物 has recorded 2 reports. Market capitalisation: €36.8bn. The latest transaction was filed on 31 March 2026 (Purchase). Among the most active insiders: 熊俊. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
君实生物 es una empresa enfocada en el sector de la salud y farmacéutico, dedicada a la investigación y desarrollo de tratamientos innovadores. Cotiza en el mercado XSHG.